Skip to main content

Table 6 Cardiovascular risk factors at the end of the study

From: Effectiveness of multidisciplinary intervention on blood pressure control in primary health care: a randomized clinical trial

Variable

Group

Multidisciplinary Program

Personalized Care

p-value

n = 113

n = 114

FBG, mg/dL

 Diabetic

137 ± 52 (32)

135 ± 36 (33)

0.905a

 Nondiabetic

92 ± 16 (68)

93 ± 15 (67)

0.712a

HbA1c, %

6.6 ± 2 (32)

6.4 ± 1 (33)

0.634a

Total cholesterol, mg/dL

191 ± 47 (107)

198 ± 47 (104)

0.263a

HDL, mg/dL

45 ± 12 (107)

45 ± 12 (104)

0.916a

LDL, mg/dL

113 ± 41 (96)

119 ± 41 (98)

0.297a

Triglyceride, mg/dL

143 (113 – 190) (107)

143 (112 – 213) (104)

0.769b

Nondiabetic, 10 years FRS, n%

 Low

47 (63)

39 (55)

0.528c

 Medium

19 (25)

24 (34)

 High

9 (12)

8 (11)

 Mean FRS

5 (2–14)

6 (3–14)

0.647b

Diabetic, UKPDS, risk 10 year, %

 CHD

12 (8 – 17) (32)

11 (6 – 19)

0.572b

 Fatal CHD

7 (4–10) (32)

6 (3 – 13)

0.682b

 Stroke

7 (5 – 12) (32)

5.5 (3 – 12)

0.993b

 Fatal Stroke

1 (1 – 2) (32)

1 (1 – 2)

0.992b

  1. FBG Fasting blood glucose, HbA1c Glycated hemoglobin, HDL High-density lipoprotein, LDL Low-density lipoprotein cholesterol, FRS Framingham risk score, CVD Cardiovascular disease. Values expressed n (%), mean and standard deviation (SD) or median and interquartile range (IQR)
  2. aStudent’s t-test
  3. bMann-Whitney U test
  4. cPerson chi-square test